These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 9293041)

  • 41. Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in humans correlates with EEG power and coherence.
    Dafters RI; Duffy F; O'Donnell PJ; Bouquet C
    Psychopharmacology (Berl); 1999 Jul; 145(1):82-90. PubMed ID: 10445376
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users.
    Back-Madruga C; Boone KB; Chang L; Grob CS; Lee A; Nations H; Poland RE
    Clin Neuropsychol; 2003 Nov; 17(4):446-59. PubMed ID: 15168910
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Empathy and aggression: two faces of ecstasy? A study of interpretative cognitive bias and mood change in ecstasy users.
    Curran HV; Rees H; Hoare T; Hoshi R; Bond A
    Psychopharmacology (Berl); 2004 May; 173(3-4):425-33. PubMed ID: 14735288
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effects of multitasking on psychological stress reactivity in recreational users of cannabis and MDMA.
    Wetherell MA; Atherton K; Grainger J; Brosnan R; Scholey AB
    Hum Psychopharmacol; 2012 Mar; 27(2):167-76. PubMed ID: 22389081
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cognitive function in ecstasy naive abstinent drug dependants and MDMA users.
    Potter A; Downey L; Stough C
    Curr Drug Abuse Rev; 2013 Mar; 6(1):71-6. PubMed ID: 23259912
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MDMA and temperature: a review of the thermal effects of 'Ecstasy' in humans.
    Parrott AC
    Drug Alcohol Depend; 2012 Feb; 121(1-2):1-9. PubMed ID: 21924843
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serotonergic function after (+/-)3,4-methylene-dioxymethamphetamine ('Ecstasy') in humans.
    Gerra G; Zaimovic A; Giucastro G; Maestri D; Monica C; Sartori R; Caccavari R; Delsignore R
    Int Clin Psychopharmacol; 1998 Jan; 13(1):1-9. PubMed ID: 9988361
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lasting neuropsychiatric sequelae of (+-)methylenedioxymethamphetamine ('ecstasy') in recreational users.
    McCann UD; Ricaurte GA
    J Clin Psychopharmacol; 1991 Oct; 11(5):302-5. PubMed ID: 1684975
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prepulse inhibition and habituation of acoustic startle response in male MDMA ('ecstasy') users, cannabis users, and healthy controls.
    Quednow BB; Kühn KU; Hoenig K; Maier W; Wagner M
    Neuropsychopharmacology; 2004 May; 29(5):982-90. PubMed ID: 14970829
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Altered response to tryptophan supplementation after long-term abstention from MDMA (ecstasy) is highly correlated with human memory function.
    Curran HV; Verheyden SL
    Psychopharmacology (Berl); 2003 Aug; 169(1):91-103. PubMed ID: 12759801
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MDMA, cortisol, and heightened stress in recreational ecstasy users.
    Parrott AC; Montgomery C; Wetherell MA; Downey LA; Stough C; Scholey AB
    Behav Pharmacol; 2014 Sep; 25(5-6):458-72. PubMed ID: 25014666
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronic MDMA (ecstasy) use, cognition and mood.
    McCardle K; Luebbers S; Carter JD; Croft RJ; Stough C
    Psychopharmacology (Berl); 2004 May; 173(3-4):434-9. PubMed ID: 15088077
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of ecstasy on cooperative behaviour and perception of trustworthiness: a naturalistic study.
    Stewart LH; Ferguson B; Morgan CJ; Swaboda N; Jones L; Fenton R; Wall MB; Curran HV
    J Psychopharmacol; 2014 Nov; 28(11):1001-8. PubMed ID: 25122044
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recreational 3,4-methylenedioxy-N-methylamphetamine (MDMA) or 'ecstasy' and self-focused compassion: Preliminary steps in the development of a therapeutic psychopharmacology of contemplative practices.
    Kamboj SK; Kilford EJ; Minchin S; Moss A; Lawn W; Das RK; Falconer CJ; Gilbert P; Curran HV; Freeman TP
    J Psychopharmacol; 2015 Sep; 29(9):961-70. PubMed ID: 25990558
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or 'ecstasy': evidence for cognitive impairment.
    Bhattachary S; Powell JH
    Psychol Med; 2001 May; 31(4):647-58. PubMed ID: 11352367
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential effects of MDMA and methylphenidate on social cognition.
    Schmid Y; Hysek CM; Simmler LD; Crockett MJ; Quednow BB; Liechti ME
    J Psychopharmacol; 2014 Sep; 28(9):847-56. PubMed ID: 25052243
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study.
    McCann UD; Mertl M; Eligulashvili V; Ricaurte GA
    Psychopharmacology (Berl); 1999 Apr; 143(4):417-25. PubMed ID: 10367560
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cognitive performance and serotonergic function in users of ecstasy.
    Verkes RJ; Gijsman HJ; Pieters MS; Schoemaker RC; de Visser S; Kuijpers M; Pennings EJ; de Bruin D; Van de Wijngaart G; Van Gerven JM; Cohen AF
    Psychopharmacology (Berl); 2001 Jan; 153(2):196-202. PubMed ID: 11205419
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antidepressant-like effects of ecstasy in subjects with a predisposition to depression.
    Majumder I; White JM; Irvine RJ
    Addict Behav; 2012 Oct; 37(10):1189-92. PubMed ID: 22704044
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Altered states: the clinical effects of Ecstasy.
    Cole JC; Sumnall HR
    Pharmacol Ther; 2003 Apr; 98(1):35-58. PubMed ID: 12667887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.